Climb Global Solutions, Inc. CLMB 深 沪
已收盘 02-06 16:00:00 美东时间
122.65
+3.950
+3.33%
华盛通- 最 高124.89
- 今 开120.82
- 成交量 4.47万股
- 最 低 120.77
- 昨 收 118.70
- 总市值 5.66亿
- 52周最高 144.85
- 市盈率 静 30.18
- 换手率 0.97%
- 52周最低 88.39
- 委 比 -3.85%
- 总股本 461.34万
- 历史最高 144.85
- 量 比 0.84
- 振 幅 3.47%
- 历史最低 1.37
- 每 手 1
- 风险率 11.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Climb Launches Strategic Partnership With Fortinet, Expanding Its Global Security Solution Stack For Resellers
Climb, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ:CLMB) announced the launch of their partnership with Fortinet, the global cybersecurity leader
2025-12-02 00:19
Climb Channel Solutions Partners With Seclore To Deliver Advanced Data Protection For Businesses
Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ:CLMB) announced the launch of their partnership with Seclore, a data security
2025-11-05 20:15
Climb Global Solutions declares $0.17 dividend
Climb Global Solutions (CLMB) declares $0.17/share quarterly dividend, in line with previous. Forward yield 0.51% Payable Nov. 17; for shareholders of record Nov. 10; ex-div Nov. 10. See CLMB Dividend...
2025-10-30 21:15
Climb Global Solutions Q3 Adj. EPS $1.31 Beats $1.10 Estimate, Sales $161.343M Beat $125.294M Estimate
Climb Global Solutions (NASDAQ:CLMB) reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $1.10 by 19.09 percent. This is a 15.48 percent decrease over earnings of $1.55 per share
2025-10-30 04:08
美股大行评级 | 上调目标价！特斯拉、赛默飞世尔、拉姆研究、波士顿科学、安诺电子、金沙集团等获众多机构评级
今日重点评级关注：摩根士丹利：维持Viking Therapeutics"超配"评级，目标价从98美元升至102美元；摩根大通：维持IDEAYA Biosciences"超配"评级，目标价从74美元升至79美元
2025-10-24 09:51
Barrington Research Maintains Outperform on Climb Global Solutions, Maintains $136 Price Target
Barrington Research analyst Vincent Colicchio maintains Climb Global Solutions (NASDAQ:CLMB) with a Outperform and maintains $136 price target.
2025-10-23 19:36
Halcyon Enters North American Distribution Partnership With Climb Channel Solutions
Halcyon, the leading anti-ransomware solution provider, today announced a new North American distribution partnership with Climb Channel Solutions, an international specialty technology distributor and wholly owned
2025-10-20 21:04
Climb Channel Solutions named as one of “America’s Greatest Companies 2025” by Newsweek
Climb Channel Solutions, a global technology distributor, has been named among Newsweek's 2025 America’s Greatest Companies. The ranking evaluates companies based on financial performance, workforce, innovation, and sustainability. Climb is recognized alongside top firms like Oracle, NVIDIA, Amazon, and Microsoft. It also ranks among the top three employers in New Jersey. CEO Dale Foster attributes the achievement to the dedication of its team an...
2025-10-02 12:51
美股大行评级 | 潜在涨幅208.48%！HC Wainwright & Co.上调Microbot Medical目标价至12美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Microbot Medical"买入"评级，目标价从9美元升至12美元；Maxim Group：维持Neuphoria Therapeutics"买入"评级，目标价从18美元升至35美元
2025-09-12 12:53
Barrington Research Maintains Outperform on Climb Global Solutions, Maintains $136 Price Target
Barrington Research analyst Vincent Colicchio maintains Climb Global Solutions (NASDAQ:CLMB) with a Outperform and maintains $136 price target.
2025-09-11 20:08
